ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC30777-10mg |
|
1881233-39-1 |
PI4KIIIbeta-IN-10
|
0 | C22H25N3O5S2 | |
GC30777-5mg |
|
1881233-39-1 |
PI4KIIIbeta-IN-10
|
0 | C22H25N3O5S2 | |
GC30777-1mg |
|
1881233-39-1 |
PI4KIIIbeta-IN-10
|
0 | C22H25N3O5S2 | |
GC30777-10mM(1mLinDMSO) |
|
1881233-39-1 |
PI4KIIIbeta-IN-10
|
0 | C22H25N3O5S2 | |
GC30776-10mg |
|
1208243-50-8 |
ARA290 (Cibinetide)
|
0 | C51H84N16O21 | |
GC30776-5mg |
|
1208243-50-8 |
ARA290 (Cibinetide)
|
0 | C51H84N16O21 | |
GC30776-1mg |
|
1208243-50-8 |
ARA290 (Cibinetide)
|
0 | C51H84N16O21 | |
GC30775-100mg |
|
51-45-6 |
Histamine (Ergamine)
|
0 | C5H9N3 | |
GC30775-10mM(1mLinWater) |
|
51-45-6 |
Histamine (Ergamine)
|
0 | C5H9N3 | |
GC30774-25mg |
|
500992-11-0 |
Tat-NR2B9c
|
0 | C105H188N42O30 | |
GC30774-10mg |
|
500992-11-0 |
Tat-NR2B9c
|
0 | C105H188N42O30 | |
GC30774-5mg |
|
500992-11-0 |
Tat-NR2B9c
|
0 | C105H188N42O30 | |
GC30774-1mg |
|
500992-11-0 |
Tat-NR2B9c
|
0 | C105H188N42O30 | |
GC30773-1g |
|
156-51-4 |
Phenelzine sulfate
|
0 | C8H14N2O4S | |
GC30773-500mg |
|
156-51-4 |
Phenelzine sulfate
|
0 | C8H14N2O4S | |
GC30773-250mg |
|
156-51-4 |
Phenelzine sulfate
|
0 | C8H14N2O4S | |
GC30772-100mg |
|
28313 |
Dopamine serotonin antagonist-1
|
0 | C18H20N4 | |
GC30772-50mg |
|
28313 |
Dopamine serotonin antagonist-1
|
0 | C18H20N4 | |
GC30772-10mg |
|
28313 |
Dopamine serotonin antagonist-1
|
0 | C18H20N4 | |
GC30772-10mM(1mLinDMSO) |
|
28313 |
Dopamine serotonin antagonist-1
|
0 | C18H20N4 | |